biote director granted options and deferred RSUs
biote Corp. director Andrew R. Heyer reported equity-based compensation awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
biote Corp. director Andrew R. Heyer reported equity-based compensation awards. He received a stock option covering 130,000 shares of Class A Common Stock at an exercise price of $2.2000 per share, expiring on May 11, 2036. All shares under this option vest on the earlier of May 12, 2027 or the day before the company’s 2027 annual stockholder meeting, subject to his continuous service. He also received 35,259 Deferred Settlement RSUs, each economically equivalent to one share of Class A Common Stock. These RSUs are fully vested at grant but will settle only when he separates from service, and his Deferred Settlement RSU balance increased to 81,382 units after this award.
Insider Trade Summary
Grant/Award: 165,259 shares
Grant/Award
2 txns
Insider
HEYER ANDREW R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Settlement RSU | 35,259 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 130,000 | $0.00 | $0.00 |
Holdings After Transaction:
Deferred Settlement RSU — 81,382 contracts (Direct);
Stock Option (Right to Buy) — 130,000 contracts (Direct)
Footnotes (3)
- F1. Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
- F2. The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the date of the Reporting Person's separation from service.
- F3. All shares subject to the option award shall vest on the earlier of May 12, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Stock options granted: 130,000 shares
Option exercise price: $2.2000 per share
Option expiration: May 11, 2036
+4 more
7 metrics
Stock options granted
130,000 shares
Stock Option (Right to Buy) granted on May 12, 2026
Option exercise price
$2.2000 per share
Exercise price for 130,000 stock options
Option expiration
May 11, 2036
Expiration date of option award
Deferred Settlement RSUs granted
35,259 units
Deferred Settlement RSU grant on May 12, 2026
Deferred RSUs after grant
81,382 units
Total Deferred Settlement RSUs following transaction
Underlying common shares (options)
130,000 shares
Underlying Class A Common Stock for option award
Underlying common shares (RSUs)
35,259 shares
Underlying Class A Common Stock for new Deferred Settlement RSUs
Key Terms
Deferred Settlement RSU, exercise price, vest, Class A Common Stock
4 terms
Deferred Settlement RSU financial
"The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred"
exercise price financial
"conversion_or_exercise_price": "2.2000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"All shares subject to the option award shall vest on the earlier of May 12, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Class A Common Stock financial
"underlying_security_title": "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did biote Corp. (BTMD) director Andrew Heyer receive in this Form 4 filing?
Andrew R. Heyer received equity compensation consisting of stock options and Deferred Settlement RSUs. The filing shows option and RSU awards that increase his potential exposure to biote Corp. Class A Common Stock through future vesting and eventual share settlement.
How many stock options were granted to Andrew Heyer by biote Corp. (BTMD)?
He was granted stock options on 130,000 shares of Class A Common Stock. These options carry a fixed exercise price and vest in the future, giving him the right, but not the obligation, to buy shares at that price if he remains in service.
What is the exercise price and expiration date of Andrew Heyer’s biote (BTMD) stock options?
The options have an exercise price of $2.2000 per share and expire on May 11, 2036. This means he may choose to buy shares at $2.2000 any time after vesting and before expiration, subject to the award’s terms and continued service.
When do Andrew Heyer’s new biote Corp. (BTMD) stock options vest?
All shares under the option vest on the earlier of May 12, 2027 or the day before biote Corp.’s 2027 annual meeting. Vesting is conditioned on his continuous service through that date, aligning his long-term incentives with ongoing board involvement.
What are Deferred Settlement RSUs granted to Andrew Heyer at biote Corp. (BTMD)?
The Deferred Settlement RSUs are fully vested awards, each economically equal to one share of Class A Common Stock. Although vested, their settlement into actual shares is deferred until Andrew Heyer’s separation from service, delaying delivery while recognizing current service.
How many Deferred Settlement RSUs does Andrew Heyer hold after this biote (BTMD) grant?
After the grant of 35,259 Deferred Settlement RSUs, his total Deferred Settlement RSU balance is 81,382 units. These RSUs are fully vested now but will convert into shares only when he leaves service, creating a deferred equity position in the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
